Aug 3 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2018 Jun 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 171 mln 132 mln 982 mln
(+29.4 pct) (-5.7 pct) (+29.6 pct)
Operating loss 35 mln loss 59 mln loss 25 mln
Recurring loss 35 mln loss 59 mln loss 24 mln
Net loss 44 mln loss 61 mln loss 39 mln
EPS loss 5.31 yen loss 8.27 yen loss 4.68 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T